Equities

Seer Inc

SEER:NSQ

Seer Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.80
  • Today's Change0.03 / 1.69%
  • Shares traded700.62k
  • 1 Year change-51.09%
  • Beta1.4787
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.

  • Revenue in USD (TTM)15.67m
  • Net income in USD-83.00m
  • Incorporated2017
  • Employees147.00
  • Location
    Seer Inc3800 Bridge Parkway, Suite 102REDWOOD CITY 94065United StatesUSA
  • Phone+1 (650) 453-0000
  • Fax+1 (302) 655-5049
  • Websitehttps://seer.bio/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fossil Group Inc1.34bn-140.12m63.52m6.10k--0.275--0.0473-2.67-2.6725.594.361.362.468.85220,038.00-14.14-4.59-20.23-7.2448.6049.48-10.41-3.631.40-3.940.473---16.05-11.09-255.75---13.84--
BioNano Genomics Inc37.47m-226.79m64.72m344.00--0.6729--1.73-6.15-6.150.9421.440.16651.034.97108,924.40-100.76-56.82-128.31-67.8327.5425.38-605.26-505.761.13-83.420.0444--29.9024.65-75.34--38.51--
Midwest Energy Emissions Corp18.48m4.79m76.44m9.0020.639.2615.264.140.03930.03930.18940.08751.4715.1415.632,053,822.0038.13-21.6555.76-47.8133.5132.8025.92-15.572.39-7.560.278---17.027.85473.32------
Virtra Inc36.11m6.67m101.77m112.0015.112.3113.382.820.60640.60643.293.960.56460.9492.94322,418.0010.437.6912.999.7069.7359.0618.4811.122.46--0.1535--34.4216.04329.6259.3430.96--
Babcock & Wilcox Enterprises Inc965.65m-96.86m106.48m2.20k------0.1103-1.08-2.4210.82-2.491.096.715.28438,932.70-9.27-5.50-16.03-11.8722.8522.90-8.47-5.301.110.5301.90--17.86-1.22-201.13--12.36--
Luna Innovations Inc116.61m-1.12m113.42m337.00--1.2025.630.9726-0.0339-0.06373.452.790.75151.262.84346,035.60-0.72310.8556-0.92921.0959.0056.43-0.96221.231.620.13660.25210.0025.1227.05-111.20--16.38--
Seer Inc15.67m-83.00m116.89m147.00--0.3047--7.46-1.29-1.290.24455.910.0351.652.35106,625.90-18.55-16.65-19.08-17.0949.76---529.52-756.7124.81--0.00--7.54--7.20--112.67--
Geospace Technologies Corp136.33m16.02m131.75m681.008.280.92664.190.96641.191.1910.1910.640.92073.607.52200,193.8010.82-5.1011.92-5.5441.3128.7011.75-8.964.52--0.00--39.5010.45153.40--11.01--
Harvard Bioscience, Inc.106.79m-8.73m137.67m391.00--2.00--1.29-0.2029-0.20292.501.580.76621.746.46273,112.50-6.26-3.29-7.60-3.8958.5256.67-8.18-4.570.9352-0.40170.341---0.9573-1.4564.11--18.10--
Northern Technologies International Corp82.70m3.66m173.66m86.0048.842.5425.402.100.37720.37728.617.250.95373.765.27961,669.605.886.297.447.7137.0133.216.167.421.86--0.052453.377.759.21-53.95-16.8734.3913.30
Data as of May 31 2024. Currency figures normalised to Seer Inc's reporting currency: US Dollar USD

Institutional shareholders

33.23%Per cent of shares held by top holders
HolderShares% Held
Invus Public Equities Advisors LLCas of 31 Mar 20244.75m7.82%
BlackRock Fund Advisorsas of 31 Mar 20243.96m6.53%
The Vanguard Group, Inc.as of 31 Mar 20242.60m4.28%
Capital Research & Management Co. (World Investors)as of 31 Mar 20242.06m3.39%
Acadian Asset Management LLCas of 31 Mar 20241.33m2.19%
Citigroup Global Markets, Inc. (Investment Management)as of 31 Mar 20241.26m2.08%
SSgA Funds Management, Inc.as of 31 Mar 20241.15m1.90%
Geode Capital Management LLCas of 31 Mar 20241.08m1.79%
Millennium Management LLCas of 31 Mar 20241.04m1.71%
Renaissance Technologies LLCas of 31 Mar 2024942.00k1.55%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.